top of page

Foundational U.S. Patent Issues for Ohio State's Electroceutical Wound Dressing Platform

Writer: Brent Toto
Brent Toto
Oct 1, 2024
2 min read

Updated: 6 days ago

COLUMBUS, Ohio — October 1, 2024 — The U.S. Patent and Trademark Office has issued U.S. Patent No. 12,102,508 B2, titled "Antimicrobial Wound Care Dressing," to the Ohio State Innovation Foundation. The patent protects the core electroceutical dressing platform that Pavaka Wound Care went on to license exclusively from The Ohio State University in December 2024.


The inventors are an interdisciplinary Ohio State team that includes Shaurya Prakash and Vishwanath V. Subramaniam (Mechanical and Aerospace Engineering) and Chandan K. Sen and Sashwati Roy, along with colleagues and trainees who worked on the technology for more than a decade.


The patent describes a wound dressing that places electrodes on a flexible substrate, connected to a compact energy source. When applied, the dressing generates a low-level electric field at the wound surface. The design is intended to fit into everyday wound care rather than require separate equipment at the bedside.


Issued patents are central to bringing new medical technology to market. They give manufacturers, clinical partners and investors confidence that a platform can be developed and protected. For Pavaka, U.S. Patent No. 12,102,508 is the foundation of an intellectual property position it has continued to build with additional applications.


Pavaka announced its exclusive license to the platform on January 27, 2025. Since then, the company has worked with The Ohio State University and its patent counsel to prosecute related applications and to file new applications covering next-generation designs.


The issuance also reflects years of investment by Ohio State and by federal research sponsors in the science behind electroceutical wound care. Pavaka's role is to carry that investment forward into a product that can be manufactured at scale in Ohio, evaluated under the appropriate U.S. Food and Drug Administration pathway and, if cleared, made available to clinicians.


Pavaka and Ohio State signed the exclusive license agreement for the platform in December 2024, about ten weeks after the patent issued.


"A strong, issued patent is the starting point for everything we build. Ohio State's inventors created a platform worth protecting, and this patent gives us the foundation to develop it into a product." — Frank Fischer, Chief Technology Officer and Co-Founder

Investigational device: Pavaka's electroceutical wound dressing has not been cleared or approved by the U.S. Food and Drug Administration and is not available for sale.


About Pavaka Wound Care: Pavaka Wound Care is a Columbus, Ohio–based medical device company developing an electroceutical advanced wound dressing for chronic and acute wounds, including wounds complicated by multidrug-resistant bacteria and biofilms. Built on technology exclusively licensed from The Ohio State University, the investigational dressing generates a low-level electric field at the wound surface. Pavaka was co-founded by CEO Brent Toto and CTO Frank Fischer. Learn more at www.pavakawoundcare.com.


Sources and further reading

Comments


bottom of page